SC
PTPI

Shay Capital’s Petros Pharmaceuticals PTPI Stock Holding History

Shay Capital’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,111
Closed -$555K – 610
2021
Q3 		$555K Buy
1,111
+156
+16% +$101K 0.07% 236
2021
Q2 		$747K Sell
955
-72
-7% -$57.6K 0.09% 201
2021
Q1 		$957K Buy
1,027
+843
+458% +$794K 0.1% 180
2020
Q4 		$202K Buy
+184
New +$173K 0.04% 235

Other funds holding PTPI

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shay Capital's PTPI Position: Q4 2021 in Review

Shay Capital sold out of Petros Pharmaceuticals (PTPI) in Q4 2021, closing a stake of 1,111 shares — an estimated $555K sold.

Shay Capital first reported a position in PTPI in Q4 2020 and held it in 4 quarters. The position peaked at $957K in Q1 2021. 18 funds tracked by Wall St. Rank hold PTPI as of Q4 2021.

  • Shay Capital reported no remaining Petros Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Shay Capital sold 1,111 Petros Pharmaceuticals shares in Q4 2021, an estimated $555K.
  • Shay Capital first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Shay Capital's Petros Pharmaceuticals position peaked at $957K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q4 2021.

Based on Shay Capital's 13F filing for Q4 2021, filed 14 Feb 2022.